BOCA RATON, Fla., Oct. 21, 2004 (PRIMEZONE) -- Sunwin International Neturaceuticals, Inc. (OTCBB:SUWN) today released an analyst report on their Company prepared by Market Advisors, Inc. The complete unedited text of the report is as follows:
Stock Symbol: SUWN.OB Shares: 34,620,000 Float: 7,200,000 Recent price: $0.25 Short term price: $1.25 Web Site: www.sunwin.biz Phone: 1-561-988-2242
NEWS FLASH: In China, Sunwin has over 500 distribution centers and their products are being sold to 28 provinces, cities and autonomous regions. Currently, they have export relationships with companies in Japan, South Korea, Singapore, Malaysia, USA, Russia and Canada. Sunwin is promoting China's traditional herbal medicines and products worldwide and there are over 10 important products from their sweetener products line in the marketplace already being manufactured.
Sunwin International Neutraceuticals, Inc. (SUWN.OB)
Investment Highlights
-- Profitable company with strong recurring revenue streams and no
debt
-- Clear, focused business strategy for substantial growth in
world's largest market
-- Recession Proof market with significant consolidation and
expansion opportunities
-- Strong balance sheet
-- Experienced management team with extensive industry knowledge
-- In 2002, Sunwin was awarded one of the 2002 state-level
biological product manufacturers in China
-- For 2003, the Company was ranked as one of the top 50 companies
of China Animal Related Health Care Products
-- Also in 2003, Sunwin received the distinction of a top ten
innovative business by the Province Government of Shandong
-- Launched a new veterinary medicine research project incorporating
elements of Nanotechnology- key new research
Sunwin International Neutraceuticals, Inc. has been recognized as one out of 2,000 Chinese Companies the government has authorized as a very important innovative high-tech pioneering business. Sunwin is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, nutraceutical products, natural sweetener (beet sugar), and animal medicine prepared from 100% organic herbal ingredients. The Company sells herbs, beet sugar and veterinary products in the People's Republic of China. Currently an industry leader in agricultural processing, Sunwin has built an impressive integrated global firm with the outsourcing and production capabilities to meet the needs of customers throughout the world. The Company also has products like specialty veterinary food ingredients and specialty feed ingredients.
One of their top products is Stevoside, which is a natural sweetener that is extracted form the leaves of the Stevia rebaudiana plant, as a food additive that is used in various products such as beverages, pastries, dairy products, candies, confections, and medicinal products. Stevoside is estimated to be approximately 200 to 300 times sweeter than general sucrose, but it has only 1/300th of the calories.
Future Growth Opportunities
The Company seeks to expand its production capabilities in the beet sugar arena as the Chinese government has recognized the strategic importance that the Beet Sugar Production has to be able to satisfy the growing demand for sugar in the rapidly developing Chinese Economy. More up-to-date production facilities will get help from the government, which is what Sunwin has as part of their business plan. We feel that as their business plan unfolds, Sunwin has the expertise to accomplish their goals of becoming an industry leader.
ANALYST -- Jeff Helleberg has over twenty years in the business and has been lead analyst for Market Advisors since 1985. Mr. Helleberg has been frequently quoted in a wide array of publications such as the Wall Street Journal, Barrons, Investors Business Daily, The Dick Davis Digest and many more. Jeff was the editor of the Marketarian Letter, a nationally syndicated stock market newsletter for over 14 years.
The information and opinions in this report were prepared by Market Advisors, Inc., which has at times served as financial relations counsel to the featured company and does receive fees for services including preparation of this report. For this report, $2,000 was received from a non- affiliated third party. This is not an offer to buy or sell securities nor should this report be construed as investment advice. Information or statements are subject to numerous risks and uncertainties that cause such statements not to prove accurate. For a more detailed disclaimer please contact MA.
About Sunwin International Neutraceuticals, Inc.
Sunwin International Neutraceuticals, Inc. ("Sunwin") is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, nutraceutical products, natural sweetener (beet sugar), and animal medicine prepared from 100% organic herbal ingredients. Sunwin International Neutraceuticals, Inc. is doing business in China through its subsidiary, Shandong Qufu Natural Green Engineering Company, Limited ("Qufu"). As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumers to provide a quality, value, and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more information about Sunwin, please visit http://www.sunwin.biz.
Safe Harbor Statement
Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.